We recommend that you upgrade to the latest version of your browser.
logo Helse Bergen

Course for professionals

MRCRM seminar series - August 2022

PI Cecilie Bredrup will give a talk about her TMF funded project "Mesenchymal stem cells transplantation in wound healing". In her talk, she will discuss cell based therapies for limbal stem cell deficiency (LSCD).

Passed
30.
August
2022
  1. 30. Aug 2022, 2:30 PM - 3:30 PM

Time and place

When

  1. 30. Aug 2022, 2:30 PM - 3:30 PM

Event type

Fagseminar

Specialties

Øyesykdommer, Immunologi og transfusjonsmedisin

Organizer

Mohn Research Centre for Regenerative Medicine
Title: Mesenchymal stem cell transplantation in limbal stem cell deficiency - Development of precision medicine
 
Abstract: Limbal stem cell deficiency (LSCD) causes discomfort and reduced vision and is a major problem in ophthalmology. Today, the treatment is transplantation of allogenic limbal stem cells, but this has its limitations. 
Mesenchymal stem cells are now emerging as a promising treatment option. The phase 1 clinical trial using these cells in patients with end-stage LSCD will be presented. 
 
Portrait Cecilie Bredrup. Photo
Photo: 
 
About the speaker: Cecilie Bredrup is an Ophthalmologist at Haukeland University Hospital and an associate professor at University of Bergen. She did her PhD in 2009 in Bergen, with the thesis "Clinical and molecular aspects of congenital hereditary eye disease".  
More about Dr Bredrup's work here. 

One of the four core projects of MRCRM is led by Dr Bredrup. More about the project here. 
 
 
 
 
 
 
 
 

Contact